Azoospermia Treatment, Zero Sperm. Real Hope.

Azoospermia is a condition where no sperm are found in a man’s ejaculate on semen analysis. It affects approximately 1% of all men and accounts for 10–15% of male infertility cases. Diagnosis requires two separate WHO 2021-standard semen analyses confirming zero sperm — both are performed in Javitri Hospital’s NABH-certified andrology laboratory. Further workup includes hormonal profile (FSH, LH, testosterone), chromosomal karyotype, Y chromosome microdeletion analysis, and scrotal ultrasound to determine the exact type and cause before recommending azoospermia treatment.

Yes, azoospermia is treatable in the majority of cases, though the approach depends on the type. Obstructive azoospermia (sperm produced but blocked) has an excellent prognosis — surgical sperm retrieval with PESA or TESA recovers sperm in close to 100% of cases. Non-obstructive azoospermia (production problem) requires TESE or micro-TESE, which finds sperm in 40–60% of cases. In hormonal cases (hypogonadotropic hypogonadism), medical treatment alone can restore sperm to the ejaculate — representing a genuine azoospermia cure without surgery. Retrieved sperm are then used with ICSI to achieve fertilisation and pregnancy.

Azoospermia causes fall into two broad categories. Obstructive causes include vasectomy, congenital bilateral absence of the vas deferens (CBAVD), epididymal blockage from past infections (TB, gonorrhoea), and ejaculatory duct obstruction. Non-obstructive causes include chromosomal abnormalities (Klinefelter syndrome 47,XXY, Y chromosome microdeletion), hormonal failure (hypogonadotropic hypogonadism), damage from chemotherapy or radiation, and undescended testes (cryptorchidism). A third category is ejaculatory dysfunction — retrograde ejaculation or spinal cord injury — where sperm are produced and the tract is open, but ejaculation itself is impaired. Identifying the exact azoospermia cause determines which treatment is most likely to succeed.

Sperm blockage treatment — the management of obstructive azoospermia — involves surgically retrieving sperm from above the point of blockage, bypassing the obstructed pathway entirely. The standard sperm blockage treatment techniques are PESA (percutaneous epididymal sperm aspiration — needle retrieval from epididymis), MESA (microsurgical epididymal sperm aspiration — open procedure, highest sperm yield), and TESA (testicular sperm aspiration — direct testicular needle retrieval). In some cases, surgical correction of the obstruction itself is possible — such as vasectomy reversal or transurethral resection of ejaculatory ducts — which may restore natural sperm flow. All sperm blockage treatment options are available at Javitri Hospital in Lucknow.

Azoospermia surgery refers to the group of minimally invasive procedures used to retrieve sperm directly from the testes or epididymis when no sperm are present in the ejaculate. The four main azoospermia surgery techniques are: PESA (percutaneous epididymal sperm aspiration), TESA (testicular sperm aspiration), MESA (microsurgical epididymal sperm aspiration), and TESE/micro-TESE (testicular sperm extraction). Most azoospermia surgery procedures are performed under local anaesthesia or light sedation with minimal downtime. Retrieved sperm are processed in the andrology lab and injected directly into eggs using ICSI on the same day as egg collection. At Javitri Hospital, all four azoospermia surgery techniques are performed by an experienced team in a NABH-certified facility.

Obstructive azoospermia means the testes produce sperm normally, but a physical blockage prevents sperm from reaching the ejaculate. It typically shows normal FSH, normal-sized testes, and responds very well to surgical sperm retrieval. Non-obstructive azoospermia (NOA) means sperm production itself is severely impaired or absent — often due to chromosomal, hormonal, or testicular damage causes. NOA is associated with elevated FSH and small or firm testes. Treatment for NOA requires TESE or micro-TESE and has a lower, but still meaningful, sperm retrieval success rate. Distinguishing between the two types is the most important step in planning azoospermia treatment — which is why comprehensive diagnosis always precedes surgery at Javitri Hospital.

Yes, in the majority of cases. Men with obstructive azoospermia have sperm retrieved successfully in close to 100% of procedures at experienced centres. Men with non-obstructive azoospermia have sperm found in approximately 40–60% of cases with micro-TESE. Once sperm are retrieved — even just a single viable sperm — ICSI can achieve fertilisation and, ultimately, a biological child. At Javitri Hospital, many men who had been told there was no hope have gone on to father biological children through this azoospermia treatment pathway.

Yes — chromosomal testing is an essential part of azoospermia treatment planning for two important reasons. First, it identifies whether the azoospermia is caused by Klinefelter syndrome (47,XXY) or Y chromosome microdeletion — which determines which azoospermia surgery technique has the best realistic chance. Second, Y chromosome microdeletions can be passed to male children born through ICSI — genetic counselling before treatment ensures the couple understands this before proceeding. At Javitri Hospital, karyotype and Y microdeletion analysis are part of our standard azoospermia workup.

If a sperm retrieval procedure does not yield viable sperm, the clinical team reviews all investigations to determine whether a different retrieval technique might be more successful — for example, proceeding from TESA to micro-TESE in non-obstructive cases. In some non-obstructive azoospermia cases where chromosomal testing shows an AZFa or AZFb deletion, sperm retrieval is unfortunately not possible with current technology. In these situations, couples are counselled about donor sperm IVF or adoption. Importantly, the thorough diagnostic workup at Javitri Hospital — including chromosomal testing — helps identify in advance which cases are most likely to succeed, avoiding unnecessary procedures.

Javitri Hospital offers the most comprehensive azoospermia treatment programme in Lucknow and Kanpur, including all four azoospermia surgery techniques (TESA, PESA, MESA, TESE), computerised ICSI, chromosomal and Y microdeletion testing, hormonal workup, NABH-certified andrology lab, and on-site sperm cryopreservation. Furthermore, Dr. Rajul Tyagi’s 30+ years of IVF and andrology expertise, with specialist training at Cleveland Clinic Ohio USA and University Hospital Brussels Belgium, ensures every azoospermia case receives an internationally benchmarked level of care. A free first consultation is available at all three clinics in Lucknow and Kanpur.